Respiratory – September 2020 Respiratory – September 2020 Verona Pharma published and presented Part A Phase 2b symptom data and initiated multiple dose part of Phase 2 trial of Ensifentrine in COPD Ensifentrine (RPL554, PDE 3 and 4 inhibitor) – […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id